drugset / Trial / NCT01150565
Safety Study of LiRIS in Interstitial Cystitis (IC) Patients
Non-randomizedParallel-groupOpen-label
Summary
The purpose of this study is primarily to evaluate the safety and tolerability of two dose levels of an investigational drug-delivery system (LiRIS) in patients who have moderate to severe symptoms of interstitial cystitis.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | — | Other |